Gary Baldwin
Overview
Gary Baldwin is a partner in Crowell & Moring's San Francisco office, where he practices in the Health Care Group. Gary's practice is focused on health plan regulatory compliance, which includes compliance with the Knox-Keene Act, Affordable Care Act and California's Medi-Cal program requirements. His compliance practice ranges from licensing filings, to financial matters, to potential regulatory enforcement actions.
Career & Education
- California
Deputy Director, Plan & Provider Relations, California Department of Managed Health Care (DMHC);
Assistant Chief Counsel, Division of Licensing, DMHC
- California
- California State University, Sacramento, B.S., chemistry
- University of California, Davis School of Law, J.D.
- California
Gary's Insights
Client Alert | 6 min read | 03.26.24
Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur.
Speaking Engagement | 09.16.21
Insights
Practices
Gary's Insights
Client Alert | 6 min read | 03.26.24
Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur.
Speaking Engagement | 09.16.21
